Recursion Pharmaceuticals, Inc. (RXRX) — SC 13G Filings
All SC 13G filings from Recursion Pharmaceuticals, Inc.. Browse 4 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (4)
- SC 13G Filing — Jul 8, 2024
-
FMR LLC Discloses 5.23% Passive Stake in Recursion Pharma
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its Chair and CEO, Abigail P. Johnson, have disclosed a significant passive stake in RECURSION PHARMACEUTICALS, INC. As of -
ARK Invest Discloses 20.6M Share Stake in Recursion Pharma
— Jan 29, 2024
ARK Investment Management LLC, a prominent investment firm, reported on January 29, 2024, that as of December 31, 2023, they beneficially own 20,654,287 shares -
State Street Corp. Discloses Initial Stake in Recursion Pharma
— Jan 24, 2024
State Street Corporation, a major financial institution, has disclosed an initial ownership stake in Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) as of Decemb
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX